We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GPVI-RBL-2H3-NFAT-Re Luciferase Cell Line: a New Cell Based System for Studying Collagen Receptor Activation
Poster

GPVI-RBL-2H3-NFAT-Re Luciferase Cell Line: a New Cell Based System for Studying Collagen Receptor Activation

GPVI-RBL-2H3-NFAT-Re Luciferase Cell Line: a New Cell Based System for Studying Collagen Receptor Activation
Poster

GPVI-RBL-2H3-NFAT-Re Luciferase Cell Line: a New Cell Based System for Studying Collagen Receptor Activation

Introduction

The response of platelets to vessel wall injury is a primary event in arterial thrombosis. Platelets respond to vessel wall injury via activation of the Collagen surface receptor Glycoprotein VI (GPVI), which accelerates the thrombotic response through release of granule contents and activation of platelet integrins.
GPVI, which represents a relevant antithrombotic pharmacological target, is a platelet membrane protein constitutively associated with the Fc Receptor y chain (FcR y). Upon activation by the specifi c ligand Collagen, GPVI induces a kinase cascade, resulting in the stimulation of PLC-y2 which fi nally leads to cytosolic Ca++ increase (Figure 1).

Advertisement